PRVL
NASDAQPrevail Therapeutics Inc.
Prevail Therapeutics Inc. (PRVL) is a Biotechnology: Biological Products (No Diagnostic Substances) company listed on NASDAQ. There were no new wire items for PRVL in the last 30 days. The most recent was published Feb 16, 2021.
Latest news
25 items- 13D/GSEC Form SC 13G/A filedSC 13G/A - Prevail Therapeutics Inc. (0001714798) (Subject)
- 13D/GSEC Form SC 13G/A filedSC 13G/A - Prevail Therapeutics Inc. (0001714798) (Subject)
- 13D/GSEC Form SC 13G/A filedSC 13G/A - Prevail Therapeutics Inc. (0001714798) (Subject)
- 13D/GSEC Form SC 13G/A filedSC 13G/A - Prevail Therapeutics Inc. (0001714798) (Subject)
- SECSEC Form 15-12B filed15-12B - Prevail Therapeutics Inc. (0001714798) (Filer)
- SECSEC Form SC 13G filedSC 13G - Prevail Therapeutics Inc. (0001714798) (Subject)
- SECSEC Form EFFECT filedEFFECT - Prevail Therapeutics Inc. (0001714798) (Filer)
- INSIDERSEC Form 4 filed by Llc Advisors Orbimed4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- INSIDERSEC Form 4: Asa Abeliovich decreased ownership by 100% to 0 units4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- INSIDERSEC Form 4 filed by M Timothy Adams4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- INSIDERSEC Form 4 filed by H. William Carson4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- INSIDERSEC Form 4 filed by Yong Dai4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- INSIDERSEC Form 4 filed by Franz Hefti4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- INSIDERSEC Form 4 filed by Brett Kaplan4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- INSIDERSEC Form 4: Emily Minkow decreased ownership by 100% to 0 units4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- INSIDERSEC Form 4 filed by Francois Nader4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- INSIDERSEC Form 4 filed by M. Kira Schwartz4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- INSIDERSEC Form 4 filed by Jeffrey Sevigny4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- INSIDERSEC Form 4 filed by Morgan Sheng4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- INSIDERSEC Form 4 filed by Ran Nussbaum4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- INSIDERSEC Form 4 filed by L Carl Gordon4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- INSIDERSEC Form 4 filed by A. Peter Thompson4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- SECSEC Form S-8 POS filedS-8 POS - Prevail Therapeutics Inc. (0001714798) (Filer)
- SECSEC Form S-8 POS filedS-8 POS - Prevail Therapeutics Inc. (0001714798) (Filer)
- SECSEC Form POS AM filedPOS AM - Prevail Therapeutics Inc. (0001714798) (Filer)
PRVL FAQ
6 questionsWhat is the latest news on PRVL?
Quantisnow has not tracked any new filings, ratings or press releases for PRVL in the last 30 days. The most recent wire item was published on February 16, 2021.Where does PRVL stock trade?
Prevail Therapeutics Inc. (PRVL) is listed on NASDAQ.What sector and industry is PRVL in?
Prevail Therapeutics Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did Prevail Therapeutics Inc. go public?
Prevail Therapeutics Inc. (PRVL) completed its IPO in 2019.What companies are similar to PRVL?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), MRNA (Moderna Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.). Compare PRVL side-by-side with any of them on Quantisnow.How can I track PRVL on Quantisnow?
Quantisnow aggregates Prevail Therapeutics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PRVL to receive live email and push alerts on every new disclosure.